0001477449-24-000150.txt : 20240604
0001477449-24-000150.hdr.sgml : 20240604
20240604160616
ACCESSION NUMBER: 0001477449-24-000150
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Raman-Tangella Vidya
CENTRAL INDEX KEY: 0001918441
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 241017963
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1717531567.xml
FORM 4
X0508
4
2024-05-31
0
0001477449
Teladoc Health, Inc.
TDOC
0001918441
Raman-Tangella Vidya
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
CHIEF MEDICAL OFFICER
1
Common Stock
2024-05-31
4
M
0
792
A
29952
D
Common Stock
2024-05-31
4
M
0
2325
A
32277
D
Common Stock
2024-05-31
4
S
0
3407
11.21
D
28870
D
Common Stock
2024-06-03
4
S
0
1122
11.157
D
27748
D
Common Stock
2024-06-04
4
S
0
468
11.04
D
27280
D
Performance Stock Units
2024-05-31
4
M
0
792
0
D
Common Stock
792
5548
D
Restricted Stock Units
2024-05-31
4
M
0
2325
0
D
Common Stock
2325
16277
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-06-04